Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations

F. Le Duff, Jean‐David Bouaziz, Éric Fontas, Michel Ticchioni, M. Viguier, O. Dereure, Pascal Reygagne, Henri Montaudié, J.‐P. Lacour, S. Monestier, M.‐A. Richard, Thierry Passeron